Search for: "Rachel Sachs"
Results 61 - 80
of 126
Sort by Relevance
|
Sort by Date
19 May 2020, 3:30 pm
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsLast week, we focused on incentives for developing clinical evidence supporting the use of remdesivir for COVID-19 and analyzed the FDA’s grant of an emergency use authorization (EUA) for the drug. [read post]
12 May 2020, 7:49 am
By Rachel Sachs, Jacob S. [read post]
How is regulatory policy influencing the development and marketing of antibody testing for COVID-19?
4 May 2020, 12:56 pm
By Nicholson Price, Rachel Sachs, Jacob Sherkow, and Lisa Larrimore OuelletteOver the last few weeks, dozens of companies have begun marketing tests intended to determine whether someone has antibodies directed to SARS-CoV-2, the virus that causes COVID-19. [read post]
30 Apr 2020, 1:53 pm
Health 110 (2005) Rachel K. [read post]
27 Apr 2020, 1:27 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowHealth systems worldwide are facing shortages of crucial medical supplies, including personal protective equipment (PPE), diagnostic testing components including kits and nasal swabs, and even ventilators or ventilator parts. [read post]
21 Apr 2020, 2:09 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowOur recent posts have highlighted shortages in three COVID-19-related knowledge goods: testing, drugs (such as those needed to put patients on ventilators), and clinical trial information about effective treatments. [read post]
15 Apr 2020, 8:14 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowIt’s now clear that expansive, population-wide testing is part-and-parcel of every successful COVID-19 containment strategy. [read post]
7 Apr 2020, 7:34 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowThe escalating pandemic has caused devastating shortages not only of ventilators and personal protective equipment like masks, but also of essential medicines needed to treat COVID-19 patients. [read post]
30 Mar 2020, 8:40 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowOne of the dizzying stream of innovation and health law stories to emerge last week is Oracle’s partnership with the White House to study unproven pharmaceuticals for treating COVID-19. [read post]
11 Mar 2020, 3:30 am
Lemley, Lisa Larrimore Ouelette, and Rachel Sachs, The Medicare Innovation Subsidy, N.Y.U. [read post]
6 Feb 2020, 1:41 pm
Sachs, Regulating Intermediate Technologies, 37 Yale J. on Reg. 219 (2020). 6. [read post]
6 Dec 2019, 4:07 am
For the employees of Goldman Sachs, there is now a rule as well. [read post]
28 Jun 2019, 6:07 am
Securities and Exchange Commission, on Friday, June 21, 2019 Tags: Capital requirements, CFTC, Derivatives, Dodd-Frank Act, Margin requirements, SEC, SEC rulemaking, Securities regulation, Swaps, Swaps entities Rent-A-Center: A $1.37 BN Reminder on Reminders Posted by Rachel Fridhandler, Sidley Austin LLP, on Saturday, June 22, 2019 Tags: Acquisition agreements, Delaware cases, Delaware law, Merger… [read post]
28 Apr 2019, 9:02 pm
Sachs, Washington University in St. [read post]
1 Feb 2019, 9:56 am
Sachs“The new proposal aims to eliminate rebates from pharmaceutical companies to pharmacy benefit managers (PBMs) in Medicare Part D and in Medicaid managed care organizations,” said Rachel Sachs, associate professor of law in the School of Law. [read post]
25 Oct 2018, 9:30 pm
But the latest health care legislation introduced in Congress and the federal government’s larger policy plan are unlikely to drive the innovations necessary to improve the health of the American people, argues Rachel Sachs, a professor at Washington University School of Law. [read post]
4 Oct 2018, 12:18 pm
Sachs“In the U.S., we give innovator pharmaceutical companies some period of exclusivity after their product comes to market, before which a biosimilar drug can be approved on the strength of the innovator drugs application in the first instance,” said Rachel Sachs, associate professor of law in the School of Law and an expert on drug policy and pricing. [read post]
10 Aug 2018, 5:15 pm
If it surfaces the same relatively unpopular songs for every listener w/in a group, that might matter v. if it randomizes w/in a group of equally unpopular similar songs.]Rachel Sachs, Regulating Intermediate Technologies Health care tech where we want to incentivize improvement of existing tech but we’ve set up the system wrong. [read post]
30 Jul 2018, 10:44 am
The 18th Annual IP Scholars Conference is next week (Aug. 9-10) at Berkeley Law, and it includes over 140 academic talks given in six parallel tracks. [read post]
14 May 2018, 8:56 am
Sachs“The administration’s blueprint contains dozens of proposals and over a hundred potential questions to explore in the future,” said Rachel Sachs, associate professor of law in the School of Law, who has written extensively on drug policy and pricing. [read post]
